Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Berna Akkus YildirimCem OnalFatih KoseEzgi OymakAli Murat SedefAli Ayberk BesenSercan AksoyOzan Cem GulerAhmet Taner SumbulSadık MuallaogluHuseyin MertsoyluGokhan Ozyigit

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2019)

Local prostate RT significantly improved OS and local control in mCRPC patients treated with abiraterone. The patients treated with primary RT had significantly less progression under abiraterone and a longer abiraterone period than those treated without local prostate RT.

Keyphrases

prostate cancer
benign prostatic hyperplasia
squamous cell carcinoma
small cell lung cancer
early stage
radiation therapy